Notably, our results revealed that CAFR secreted markedly higher levels of TGF-β1 than CAFS derived from radiosensitive CRC patients, suggesting that this variation in TGF-β1 secretion may be a critical driver of enhanced radioresistance. Here, TGFB1 is linked to colorectal carcinoma.